Kaspersky Lab releases Kaspersky Anti-Virus for Apple Macs

Kaspersky Lab has released of a new product that protects Macs and other computers connected to Macs from all types of malware.

Kaspersky Anti-Virus for Mac is based on Kaspersky Lab’s new antivirus engine which dramatically increases system scanning speed thanks to improved processing of objects and optimized use of system resources, particularly on dual- and quad-core processor platforms.

The new product for Mac OS X (versions 10.4.11 and higher) combines the advantages of the new antivirus engine with a security approach that is based on protecting home or corporate networks from multiplatform IT threats. Kaspersky Anti-Virus for Mac protects against Mac OS malware (Trojans) as well as combating similar threats, including viruses, Trojans, and worms for Windows and Linux operating systems.

The release of Mac OS X made the interaction of multiplatform computers considerably easier and Mac computers have now become an integral part of many corporate and home networks. These unprotected machines are like open gates through which malicious programs can penetrate any computer in a network which, in some organizations, could result in tens of thousands of machines being affected.

In order to protect Windows PCs on mixed networks more effectively, Kaspersky Lab’s new product has access to the company’s global antivirus database that includes information on more than 20 million malicious programs for a range of platforms. The antivirus databases for Kaspersky Anti-Virus for Mac are updated hourly, as are the company’s antivirus products for Windows and Unix operating systems. This ensures that users are protected against the very latest malware that appear in large numbers for multiple platforms every day on the Internet.

Kaspersky Anti-Virus for Mac scans files and email attachments downloaded from the Internet. The new product is also exceptional for its distributed use of system resources: when user activity increases, the priority of the antivirus scanner declines, offering the user complete access to the computer’s system resources and increasing the performance of user applications.

Kaspersky Anti-Virus for Mac also protects shared folders on virtual machines which are gaining in popularity with both corporate and home users. This prevents the transfer of malware from Windows or Unix virtual systems to the work environment, which is of great importance for those working with several operation systems on a Mac computer.

Being well aware that an attractive interface is a must for Mac applications, Kaspersky Lab has equipped its new product with an animated interface that is user-friendly both for novices and more experienced users. Information about the protection status and any necessary user actions are presented in a graphic format that is easy to understand. The new product includes an automated mode for operations with applications, which means the program takes decisions automatically and doesn’t bother users with unnecessary requests.

Kaspersky Anti-Virus for Mac was especially designed to meet the needs of the Mac OS X operating system, offering complete compatibility with all versions of the OS from 10.4.11. Other technical requirements include: a Macintosh with the Intel processor, 512 MB available RAM and 80 MB available hard drive space.

Find out more information here: www.kaspersky.com/kaspersky-anti-virus-for-mac

MacDailyNews Take: If you’re on a network with Windows boxes especially, even though the vast majority of malware will not run on Macs, you may wish to help protect Windows PCs which have difficulty protecting themselves. Nobody likes a Typhoid Mary, especially your company’s IT guy(s). So, even if your Mac is immune most malware, products such as this can prevent your Mac from being a carrier in mixed network situations. It’s a matter of being part of the solution (as efficiently as possible), not part of the problem, especially on corporate networks.

MacDailyNews Note: We have not tested Kaspersky Anti-Virus for Mac. This is merely news of its availability.


  1. Very true MDN re: Typhoid Mary. I used Virex back in the OS 9 days to make sure I wasn’t passing along junk to the PC users on the network. Twice, I was the one who told PC users that they had a virus on their computers when it came in an attachment to me.

  2. @ Sarasota

    “vaporware” is something promised-but never delivered..

    According to this article, this has actually been released for Mac users–
    But, on the other hand (like you said)– I can’t see very many Mac-heads lining up to buy it..

  3. Okay, can someone confirm? I’ve heard here and elsewhere that there are no Mac viruses (for many reasons, including Unix priv reasons). Then I read. Elsewhere I read there are ‘a few’ Mac viruses. So, which is it? (And I do know the differences between viruses and trojans and what needs social engineering, etc.).

  4. @MDN Take

    Infecting others while staying immune is the entire point! We should be handing out blankets and flash drives! ” width=”19″ height=”19″ alt=”wink” style=”border:0;” />

  5. @ LeeSweet
    There have been a few “proof of concept” trojans that affect the Mac .. but AFAIK — there haven’t been any actual viruses (for the Mac)– since the adoption of OSX ..

    Last I heard, there were only about 60-70 which would affect OS 9 (and below) — but back then, WinDoze still suffered through tens of thousands ..

  6. As far as the MDN take…I will be more than happy to run AV software as long as the cost comes out of the budgets of Windows users in the company and not mine. Running computers that are not so easily hacked IS the only solution.

    just my $0.02

  7. @Agree with your take
    I totally forgot about Virex – rock on!

    vaporware = Phantom Game Console – who’s HQ was on Longboat, no wait, 2 blocks from the Hollywood 20, no wait Longboat again – that’s a good local example you can appreciate

    this is a real product; MDM’s take is right

Reader Feedback

This site uses Akismet to reduce spam. Learn how your comment data is processed.